Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Sell
47
MEPDF Quote, Financials, Valuation and Earnings
Last price:
$16.50
Seasonality move
:
2.46%
Day range:
$16.50 - $16.50
52-week range:
$13.24 - $17.57
Dividend yield:
2.59%
P/E ratio:
12.54x
P/S ratio:
0.14x
P/B ratio:
0.80x
Volume:
--
Avg. volume:
--
1-year change:
24.62%
Market cap:
$3.4B
Revenue:
$24.1B
EPS (TTM):
$1.32
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Medipal Holdings Corp. has -- downside to fair value with a price target of -- per share.
MEPDF vs. S&P 500
-
Over the past 5 trading days, Medipal Holdings Corp. has underperformed the S&P 500 by -1.95% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Medipal Holdings Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Medipal Holdings Corp. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Medipal Holdings Corp. reported revenues of $6.5B.
Earnings Growth
-
Medipal Holdings Corp. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Medipal Holdings Corp. reported earnings per share of $0.41.
Enterprise value:
2.7B
EV / Invested capital:
0.50x
Price / LTM sales:
0.14x
EV / EBIT:
7.63x
EV / Revenue:
0.11x
PEG ratio (5yr expected):
2.46x
EV / Free cash flow:
6.00x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
5.67x
Gross Profit (TTM):
$1.7B
Return On Assets:
2.72%
Net Income Margin (TTM):
1.38%
Return On Equity:
6.73%
Return On Invested Capital:
6.45%
Operating Margin:
1.16%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $24.8B | $24B | $25.1B | $6.1B | $6.5B | |
| Gross Profit | $1.6B | $1.6B | $1.7B | $405.1M | $422M | |
| Operating Income | $347.4M | $373.5M | $358.7M | $93M | $74.8M | |
| EBITDA | $464M | $495.8M | $482.6M | $124.2M | $106.1M | |
| Diluted EPS | $1.31 | $1.46 | $1.32 | $0.41 | $0.41 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $10.8B | $8.4B | $8.4B | $9.1B | $9.3B | |
| Total Assets | $15.5B | $12B | $12.2B | $13.1B | $12.9B | |
| Current Liabilities | $8.8B | $6.9B | $7B | $7.4B | $7.4B | |
| Total Liabilities | $9.6B | $7.3B | $7.4B | $7.8B | $7.7B | |
| Total Equity | $5.9B | $4.7B | $4.8B | $5.3B | $5.2B | |
| Total Debt | $271.3M | $470.5M | $246.9M | $303M | $267.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2011-03-31 | 2012-03-31 | 2013-03-31 | 2012-03-31 | 2013-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $568.5M | -$21.7M | $693.8M | $311.8M | $559.2M | |
| Cash From Investing | -$289.1M | -$152.9M | -$168.1M | -$43.7M | -$209.3M | |
| Cash From Financing | -$116M | -$90.8M | -$176.7M | -$45.5M | -$33.1M | |
| Free Cash Flow | $296.5M | -$231.9M | $455.9M | $235.6M | $359.2M | |
MEPDF
Sector
Market Cap
$3.4B
$28.1M
Price % of 52-Week High
93.91%
51.39%
Dividend Yield
2.59%
0%
Shareholder Yield
2.54%
-1.49%
1-Year Price Total Return
24.62%
-17.13%
Beta (5-Year)
0.358
0.518
Dividend yield:
2.59%
Annualized payout:
$0.42
Payout ratio:
52.78%
Growth streak:
2 years
Technicals
8-day SMA
Sell
Level
$16.50
200-day SMA
Buy
Level
$16.14
Bollinger Bands (100)
Buy
Level
15.88 - 16.48
Chaikin Money Flow
Sell
Level
-9.7K
20-day SMA
Sell
Level
$16.50
Relative Strength Index (RSI14)
Buy
Level
99.30
ADX Line
Buy
Level
95.33
Williams %R
Sell
Level
0
50-day SMA
Buy
Level
$16.45
MACD (12, 26)
Buy
Level
0.02
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Neutral
Level
4.8K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.9006)
Buy
CA Score
(Annual)
Level (-0.2926)
Buy
Beneish M-Score
(Annual)
Level (-2.5089)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-0.1989)
Buy
Piotroski F Score
(Annual)
Level (8)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Medipal Holdings Corp. manages its group companies which are engaged in the sale of pharmaceuticals, cosmetics, and daily necessities. Its operations are carried out through the following segments: Prescription Pharmaceutical Wholesale Business; Cosmetics, Daily Necessities, and Over-The-Counter (OTC) Pharmaceutical Wholesale Business; and Animal Health Products Wholesale Business. The Prescription Pharmaceutical Wholesale Business segment conducts wholesale business for hospitals, clinics, and dispensing pharmacies. The Cosmetics, Daily Necessities, and OTC Pharmaceutical Wholesale Business segment deals with wholesale business for drugstores, home centers, convenience stores, and supermarkets. The Animal Health Products Wholesale Business segment handles wholesale business for animal hospitals, farms, agricultural cooperatives, and processed food manufacturers. The company was founded on October 8, 1898 and is headquartered in Tokyo, Japan.
Stock Forecast FAQ
In the current month, MEPDF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MEPDF average analyst price target in the past 3 months is --.
-
Where Will Medipal Holdings Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Medipal Holdings Corp. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Medipal Holdings Corp.?
Analysts are divided on their view about Medipal Holdings Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Medipal Holdings Corp. is a Sell and believe this share price will rise from its current level to --.
-
What Is Medipal Holdings Corp.'s Price Target?
The price target for Medipal Holdings Corp. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MEPDF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Medipal Holdings Corp. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of MEPDF?
You can purchase shares of Medipal Holdings Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Medipal Holdings Corp. shares.
-
What Is The Medipal Holdings Corp. Share Price Today?
Medipal Holdings Corp. was last trading at $16.50 per share. This represents the most recent stock quote for Medipal Holdings Corp.. Yesterday, Medipal Holdings Corp. closed at $16.50 per share.
-
How To Buy Medipal Holdings Corp. Stock Online?
In order to purchase Medipal Holdings Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get MEPDF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MEPDF
Sector
P/E ratio
12.54x
23.89x
PEG ratio
2.46x
-0.01x
P/B ratio
0.80x
1.81x
Price / LTM sales
0.14x
1.59x
Growth Metrics
MEPDF
Sector
Revenue growth
5.29%
4.62%
Earnings growth
0.59%
11.06%
Revenue (5-year growth)
-4.25%
6.5%
Earnings forecast
--
-$0.21
Profitability
MEPDF
Sector
Profitability FY 2024
$1.6B
$3.6M
Return on invested capital
6.45%
-31.84%
Return on assets
2.72%
-27.96%
Return on equity
6.73%
-37.63%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
9
Estimated Next Earnings Date
Feb
4
Balance Sheet
MEPDF
Sector
Total cash
$1.9B
$26.4M
Short term investments
$2.1M
$25.7M
Total assets
$12.2B
$76.9M
Long term debt
$267.2M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 4.67% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.48% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 1.12% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
